From: Myasthenia gravis following human papillomavirus vaccination: a case report
Author | Age/Sex | Vaccine Type | Time to onset | Initial symptoms | Treatment | Prognosis (Time to recovery) | Thymoma | MGFA Class |
---|---|---|---|---|---|---|---|---|
Biron [9] | 48/M | HBV | 1 mo after 2nd shot | Ocular | Edrophonium,, plasma exchange, cyclophosphamide, steroid | Improved. (After 30 PE) | + | I |
Bahri [10] | 46/F | HBV | 1mo after 2nd shot | Ocular, bulbar | Pyridostigmine, steroid | Improved (Not mentioned) | + | IIb |
Takizawa [8] | 69/M | BCG | 6 wks | Ocular | Pyridostigmine | Improved (70 days) | – | IIa |
Our case | 23/F | HPV | 3 d after 2nd shot | Ocular, bulbar | Pyridostigmine, steroid, IVIG | Improved (84 days) | – | V |